46.81
0.65 (1.41%)
| Penutupan Terdahulu | 46.16 |
| Jumlah Dagangan | 1,238,510 |
| Harga / Jualan (P/S) | 13.14 |
| Harga / Buku (P/B) | 23.92 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -2.55 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 20.22% |
| Nisbah Semasa (MRQ) | 10.25 |
| Aliran Tunai Operasi (OCF TTM) | -229.84 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -134.32 M |
| Pulangan Atas Aset (ROA TTM) | -50.15% |
| Pulangan Atas Ekuiti (ROE TTM) | -106.71% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Scholar Rock Holding Corporatio | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -2.5 |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | -0.5 |
| Purata | 0.00 |
|
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 4.35% |
| % Dimiliki oleh Institusi | 118.63% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| HALLAL DAVID | - | 48.16 | -36,652 | -1,765,160 |
| WOODS KEITH | - | 48.61 | -48,034 | -2,334,933 |
| Jumlah Keseluruhan Kuantiti Bersih | -84,686 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -4,100,093 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 48.39 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| WOODS KEITH | Pegawai | 24 Sep 2026 | Dibuang (-) | 48,034 | 48.61 | 2,334,933 |
| HALLAL DAVID | Pegawai | 21 Sep 2026 | Dibuang (-) | 36,652 | 48.16 | 1,765,160 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |